Orchestra BioMed Holdings, Inc.
OBIO
$2.60
$0.051.96%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.69% | 243.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.69% | 243.08% | |||
| Cost of Revenue | 4.55% | -24.14% | |||
| Gross Profit | -4.13% | 322.56% | |||
| SG&A Expenses | 0.02% | 6.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.89% | 16.89% | |||
| Operating Income | -2.15% | -13.46% | |||
| Income Before Tax | -3.24% | -16.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.24% | -16.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.24% | -16.09% | |||
| EBIT | -2.15% | -13.46% | |||
| EBITDA | -2.17% | -13.53% | |||
| EPS Basic | -2.81% | -15.57% | |||
| Normalized Basic EPS | -2.80% | -15.57% | |||
| EPS Diluted | -2.81% | -15.57% | |||
| Normalized Diluted EPS | -2.80% | -15.57% | |||
| Average Basic Shares Outstanding | 0.41% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.41% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||